From this cohort, three at risk individuals and two familial breast cancer patients were positive for clearly pathogenic BRCA1 mutations and only six familial breast cancer patients were positive for clearly pathogenic BRCA2 mutations. This evidence concerns the gene BRCA2 and breast cancer.